Taiho Oncology, Inc.
Mark Henning has a diverse work experience spanning various industries. Mark is currently serving as an Associate Director of Commercial Data & Analytics at Taiho Oncology, Inc. Since 2023. Prior to this, they worked at Bardess Group Ltd. from 2020 to 2023 in the role of Associate Director of Customer Success & Business Intelligence Developer. Before that, Mark was a Senior Business Intelligence Developer at Integrated Data Services, Inc. from 2019 to 2020. Mark also worked as a Senior Consultant at Deloitte from 2018 to 2019, and as a Senior Data Analyst at Accenture from 2017 to 2018. Earlier in their career, Mark served as an Auditing Analyst / Contractor at 11th Hour Service from 2015 to 2017 and as a Medic in the Army Healthcare from 2011 to 2014. Mark has also held positions such as Front Desk/Concierge at Historic Key West Inns in 2009, Management Trainee at Enterprise Rent-A-Car in 2008, and Research Analyst/Administrative Support at World Travel & Tourism Council in 2007. Mark's work experience reflects their expertise in data analytics, business intelligence, consulting, and healthcare.
Mark Henning's education history is as follows:
In 2022 to 2023, they attended Columbia Business School and completed the Senior Executive Program in Venture Capital & Private Equity.
From 2015 to 2017, they pursued a Master of Arts (M.A.) degree in Applied Economics at The Johns Hopkins University - Carey Business School.
In 2006 to 2007, they studied at London Metropolitan University, obtaining a Master of Arts (MAc) degree in International Tourism Development.
From 2002 to 2005, they attended Niagara University and earned a Bachelor of Science (BS) degree in Tourism Marketing/Hospitality Management.
In terms of certifications, Mark Henning obtained several, including:
- Venture Capital Private Equity Program from Columbia Business School Executive Education in February 2023.
- Digital Transformation in Healthcare (Online) from Emeritus in January 2023.
- Blockchain in Business (Online): Beyond the Hype from Emeritus in October 2022.
- Leading Digital Transformation from Columbia Business School in October 2022.
- Python For Managers (Online) from Emeritus in September 2022.
- Venture Capital Private Equity from Emeritus in July 2022.
- Qlik Sense Data Architect: Qlik Sense - June 2019 from Qlik in June 2020.
This person is not in the org chart
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com